TCGX

TCGX Acquisition Corp

10.02

Oct 19 • 3:59 PM ET -2.28 (-18.54%)

10.10

Aftermarket • 7:30 PM ET +0.08 (0.80%)

Financial Shell Companies USA Micro NASD

Today, 7:40 AMTCGX Acquisition to merge with TriGemX Bio and take it public on Nasdaq as TriGemX Bio, Inc.

Scroll to Statements

Index	-
Market Cap	113.23M
Enterprise Value	113.27M
Income	-
Sales	-
Book/sh	-0.00
Cash/sh	0.00
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	-
IPO	Aug 05, 2026

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	-
P/C	-
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	0.02
Current Ratio	0.02
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / Yes

EPS (ttm)	-
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-
Sales Q/Q	-
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	22.94%
Insider Trans	0.00%
Inst Own	8.91%
Inst Trans	-
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-23.10%
SMA50	-26.69%
SMA200	-26.38%
Trades

Shs Outstand	9.15M
Shs Float	8.71M
Short Float	0.61%
Short Ratio	0.74
Short Interest	0.05M
52W High	18.91 -47.01%
52W Low	10.30 -2.72%
Volatility	15.11% 7.88%
ATR (14)	1.17
RSI (14)	30.10
Beta	-
Rel Volume	25.07
Avg Volume	71.66K
Volume	1,796,223

Perf Week	-18.64%
Perf Month	-31.60%
Perf Quarter	-
Perf Half Y	-
Perf YTD	-2.72%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	12.30
Price	10.02
Change %	-18.54%

Today 07:00AM

TriGemX Bio and TCGX Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Company to Develop Elismetrep, a Potential First-in-Class Treatment for Migraine

(Business Wire) -18.54%

TCGX Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on May 26, 2026 and is headquartered in Palo Alto, CA.

M.D.Dr. Chen-Ming Yu M.B.A.

Chief Financial OfficerMr. Craig David Skaling

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TCGX

TCGX Acquisition Corp

Upgrade your Finviz experience